SR-9009 (Stenabolic): The Rev-Erbα Endurance Compound
Summary
- What: SR-9009 (Stenabolic) is a synthetic Rev-Erbα agonist that reprograms circadian metabolic gene expression toward enhanced oxidative capacity.
- Mechanism: Activates Rev-Erbα, which suppresses BMAL1 and triggers downstream mitochondrial biogenesis, fatty acid oxidation, and glucose disposal.
- Who it’s for: Endurance athletes, Enhanced Men doing cardio work, and anyone exploring exercise-mimetic pharmacology.
- Differentiator: Short half-life (~4 hours) demands multi-dose day; oral bioavailability in humans is limited.
- Natural Plus angle: Low-dose, cycled, paired with actual cardio, Stenabolic amplifies training, does not replace it.
Deep Biochemistry
Rev-Erbα (NR1D1) is a nuclear receptor that sits at the junction of circadian rhythm and metabolism. It represses transcription of BMAL1, a core clock gene, and controls expression of genes governing lipid metabolism, inflammation, and mitochondrial function. Burris and colleagues at Scripps developed SR-9009 as a pharmacological Rev-Erbα agonist.
When SR-9009 binds Rev-Erbα, the receptor represses BMAL1 and activates a suite of metabolic programs: increased mitochondrial content, higher fatty acid oxidation, reduced plasma triglycerides, and improved glucose tolerance. In rodents, SR-9009 produced endurance gains that mimicked exercise training. These are the findings that made the compound famous in biohacking circles.
Human pharmacokinetics are the main asterisk. SR-9009 has poor oral bioavailability in rodents (sub-10%) and low-millimolar concentrations are needed for receptor activation. Half-life is ~4 hours. Many practitioners therefore split dose 3-4x daily. Injectable routes have been explored but remain off-label.
Tony huge laws of Biochemistry Physics Applied
This compound illustrates Law 2 of the tony huge laws of biochemistry physics, Chain Optimization. the metabolic chain from glucose/fatty acid uptake to ATP production passes through mitochondrial content, enzyme density, and oxidative capacity. SR-9009 optimizes the whole chain at once via the Rev-Erbα node, it is not pushing one link in isolation but reprogramming the transcription factor that controls many links simultaneously. This is the assembly-line analogy: rather than speeding one station, Rev-Erbα agonism upgrades the blueprint for the entire production line.
Natural Plus Protocol
- Dose: 10-30 mg per day, split 3-4 doses (due to short half-life).
- Timing: Morning, pre-workout, mid-afternoon, evening.
- Cycling: 8 weeks on, 4 weeks off. Do not stack indefinitely.
- Stack partners: Actual cardio (the amplification is real but requires a training signal).
- Bloodwork: Lipid panel, HbA1c, fasting glucose at baseline and week 8.
Stacking Recommendations
| Stack Compound | Pathway | Why It Synergizes |
|---|---|---|
| Cardarine (GW-501516) | PPAR-delta | Different nuclear receptor, complementary fatty acid oxidation pathway. |
| Methylene Blue | ETC electron donor | Direct mitochondrial support pairs with SR-9009 biogenesis signal. |
| MOTS-c | Mitochondrial peptide | Mitochondrially-encoded peptide; independent exercise-mimetic axis. |
Target Audience
Endurance athletes plateauing on training alone. Men doing 45+ minute cardio sessions who want metabolic amplification. Experimental biohackers exploring exercise-mimetic pharmacology.
Timeline / Results Table
| Timeframe | What to Expect |
|---|---|
| Week 1-2 | Subjective improvement in endurance sessions, same effort, lower HR. |
| Week 4 | Measurable cardiovascular gains; easier fat loss on a given deficit. |
| Week 8 | Lipid panel typically shows reduced triglycerides. |
| Week 12 | Cycle off. Retain most gains if cardio training is maintained. |
Interesting Perspectives
The contrarian take: SR-9009 was hyped in 2013-2015 as “exercise in a pill.” Reality is more nuanced. It amplifies training, but the compound alone produces modest effects. The athletes who got the biggest gains were the ones already training hard.
Emerging angle: Rev-Erbα is increasingly studied in cardiology and metabolic disease. The long-term safety profile in humans is not established, most data is rodent. Treat this as an experimental compound, not a supplement.
Underground pattern recognition: users who stack SR-9009 with actual high-volume cardio see the best body-recomposition results. Those who use it as a replacement for training get nothing.
Questions people ask
What is SR-9009?
SR-9009 (Stenabolic) is a synthetic Rev-Erba agonist that reprograms metabolic gene expression to enhance endurance and fat oxidation.
How much SR-9009 should I take?
10-30 mg per day split into 3-4 doses due to short half-life.
Is SR-9009 safe?
Human safety data is limited. Treat as experimental. Cycle 8 weeks on, 4 off, with bloodwork.
Can I stack with Cardarine?
Yes, different nuclear receptors, additive endurance effects.
Who should use SR-9009?
Endurance athletes and experienced biohackers exploring exercise-mimetic compounds with actual cardio training.
References
- Solt LA, et al. “Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists.” Nature, 2012.
- Woldt E, et al. “Rev-erb-alpha modulates skeletal muscle oxidative capacity by regulating mitochondrial biogenesis and autophagy.” Nat Med, 2013.
- Burris TP, et al. “Nuclear receptors and their selective pharmacologic modulators.” Pharmacol Rev, 2013.
- Duez H, Staels B. “Rev-erb alpha: an integrator of circadian rhythms and metabolism.” J Appl Physiol, 2009.
- Banerjee S, et al. “Pharmacological targeting of the mammalian clock regulates sleep architecture and emotional behaviour.” Nat Commun, 2014.
Education and personal experience only, not medical advice. 18+. Talk to a licensed doctor before you change anything about your health.
Read nextAniracetam vs Piracetam